U.S. Reshoring and Nearshoring: A Sustainable Economic Tailwind

Summary

• U.S. companies are concluding a third quarter earnings season with net profit margins near 13.1%, exceeding the five-year average.
• Major U.S. & global firms have announced approximately $1.5 trillion in multiyear nearshoring & reshoring investments across technology, pharmaceuticals, & industrials.
• Specific technology investments include Apple ($600 billion), Nvidia ($500 billion), & IBM ($150 billion).
• Specific healthcare investments include Johnson & Johnson ($55 billion), AstraZeneca ($50 billion), Eli Lilly ($50 billion), & Bristol Myers Squibb ($40 billion).
• The U.S. now hosts over 5,400 data centers, surpassing the combined total of the next 24 countries.
• Government incentives such as the CHIPS & Science Act, Inflation Reduction Act, Infrastructure Investment & Jobs Act, & tariffs are accelerating corporate onshoring decisions.
• A survey indicates 29% of U.S. firms are actively reshoring sourcing or production, while approximately 96% of CEOs are evaluating or implementing reshoring initiatives.
• AI & automation are transforming the industrial workforce by creating higher-skilled, higher-wage manufacturing roles while deploying advanced automation to offset domestic labor costs.
• Major factory projects are expected to create tens of thousands of construction & engineering jobs through 2030.
• The reindustrialization of America is evolving from a pandemic-era reaction into a structural cycle expected to shape investment, employment, & infrastructure for decades.
• Investors remain concerned about market levels & the possibility of an AI bubble despite the strong earnings performance.